REMI (Remedent) Research & Development: $0.00 Mil (TTM As of Dec. 2020)


REMI Remedent Inc REMI
12 GF Score
Price $0.00
View Full Analysis

What is Remedent Research & Development?

Remedent REMI +16.67% 12 Research & Development is $0.00 Mil as of Dec. 2020. GuruFocus rates REMI with a GF Score™ of 12/100.

Research & Development is the aggregate amount of research and development expenses during the year. Remedent's Research & Development for the three months ended in Dec. 2020 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2020 was $0.00 Mil.

Remedent  (OTCPK:REMI) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Remedent Research & Development Related Terms

Remedent Research & Development Historical Data

* Premium members only.

The historical data trend for Remedent's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Remedent Research & Development Chart

Remedent Annual Data
Trend Mar11 Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.01 0.00 0.00 0.00

Remedent Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
REMI
12GF Score
Remedent Inc REMI
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Remedent Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.00 Mil mean?
Remedent (REMI) has a Research & Development of $0.00 Mil as of Dec. 2020. Research and development expense is the total cost for research and development activities. View historical data on Remedent and its competitors.
Is Remedent's Research & Development too high?
Remedent's current Research & Development is $0.00 Mil. Overall, Remedent has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Remedent's Research & Development compare to SECI and RSCF?
Remedent's Research & Development of $0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Remedent and its competitors. Remedent's current Research & Development is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Remedent stock overvalued right now?
Remedent (REMI) has a current Research & Development of $0.00 Mil. The current Research & Development is $0.00 Mil. Remedent's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Remedent (REMI), the current Research & Development is $0.00 Mil as of Dec. 2020. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Remedent Business Description

Address Zuiderlaan 1-3, Bus 8, Ghent, BEL, 9000
Remedent Inc is a manufacturer of cosmetic dentistry products in Europe. The company is engaged in the research, development, and manufacturing of oral care and cosmetic dentistry products. It designs, develops, manufactures, and distributes cosmetic dentistry products, including a full line of professional dental products that are distributed in Europe, Asia, the Middle East, and the United States.
12GF Score

Get the complete analysis for REMI

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price